The South San Francisco company intends to use the funding to launch its pivotal trial for its blood-based colorectal cancer screening and submit its test for parallel review for CMS coverage.
How to turn analytics into actual policy outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results